News

Everyday Health on MSN4h
FDA Approves New Preventive Drug for Hereditary Angioedema (HAE)
The antibody-based drug Andembry is the first to target factor XIIa, a protein responsible for swelling in people with this ...
The American Journal of Managed Care9h
FDA Approves Garadacimab-gxii in Hereditary Angioedema
Garadacimab-gxii is the first and only treatment that targets factor XIIa (FXIIa) for the prophylactic prevention of reditary ...
MPR8h
FDA Approves Andembry for Prophylactic Use in Hereditary Angioedema
The Food and Drug Administration (FDA) has approved Andembry ® (garadacimab-gxii) for prophylactic use to prevent attacks of hereditary angioedema (HAE) in adult and pediatric pa ...
Fierce Pharma9h
With FDA nod for HAE drug Andembry, CSL set to compete with Takeda's Takhzyro
With the FDA's approval of hereditary angioedema preventative treatment Andembry, CSL is ready to take on Takeda’s ...
MedPage Today3h
FDA Approves Once-Monthly Hereditary Angioedema Drug
Anti-factor XIIa biologic garadacimab (Andembry) got the FDA greenlight for use in preventing hereditary angioedema (HAE) attacks in adult and pediatric patients ages 12 years and older, CSL announced ...
Medscape12h
Home Monitoring Kits May Aid Diuretic Dosing
“Currently, optimal measures for diuretic titration are lacking,” said Meekers, a cardiologist at Ziekenhuis Oost-Limburg ...